Oncolytic measles virus efficacy in murine xenograft models of atypical teratoid rhabdoid tumors

Neuro-Oncology - Tập 17 Số 12 - Trang 1568-1577 - 2015
Adam Studebaker1,2,3,4,5, Brian Hutzen1,2,3,4,5, Christopher R. Pierson1,2,3,4,5, Terri A. Shaffer1,2,3,4,5, Corey Raffel1,2,3,4,5, Eric M. Jackson1,2,3,4,5
1Animal Resources Core, Research Institute at Nationwide Children's Hospital, Columbus, Ohio (T.A.S.)
2Center for Childhood Cancer and Blood Diseases, Research Institute at Nationwide Children's Hospital, Columbus, Ohio (A.W.S., B.H.)
3Department of Neurological Surgery and Pediatrics, University of California, San Francisco, California (C.R.)
4Department of Neurosurgery, Johns Hopkins University, Baltimore, Maryland (E.M.J.)
5Nationwide Children's Hospital Department of Pathology and Laboratory Medicine and Departments of Pathology and Anatomy, The Ohio State University College of Medicine, Columbus, Ohio (C.R.P.)

Tóm tắt

Từ khóa


Tài liệu tham khảo

Biegel JA Zhou JY Rorke LB Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res. 1999;59 (1):74–79.

Biegel JA Tan L Zhang F Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res. 2002;8 (11):3461–3467.

10.1038/28212

10.3109/01913129709021935

10.1002/cncr.20872

10.1158/1078-0432.CCR-08-2091

Biegel JA . Molecular genetics of atypical teratoid/rhabdoid tumor. Neurosurg Focus. 2006;20 (1):E11–E10.

10.1016/j.tips.2007.05.005

10.1038/nrc1750

10.1517/14712598.8.2.213

10.1007/s10549-009-0602-z

10.1158/1078-0432.CCR-07-1306

10.1002/pros.20857

10.1158/0008-5472.CAN-09-2762

10.1089/hum.2008.035

10.1016/j.mayocp.2014.04.003

10.1002/rmv.430

10.1007/978-3-540-70617-5_11

10.1182/blood.V97.12.3746

Peng KW TenEyck CJ Galanis E Intraperitoneal therapy of ovarian cancer using an engineered measles virus. Cancer Res. 2002;62 (16):4656–4662.

10.1093/neuonc/noq057

10.1093/neuonc/nor231

10.1016/j.ejca.2007.03.003

Phuong LK Allen C Peng KW Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme. Cancer Res. 2003;63 (10):2462–2469.

10.1073/pnas.2036535100

10.1016/j.ctrv.2010.12.003

10.1177/0141076813494196

10.2174/138920112800958904

10.1038/cgt.2011.7

10.1038/nrmicro3140

10.1016/j.trsl.2012.12.010

10.1038/nbt.2287

10.4161/onci.24612

10.1002/pbc.22724

10.1038/clpt.2010.211

10.1158/1078-0432.CCR-07-1330

10.1016/j.molonc.2013.05.004

10.1002/pbc.21578

10.1200/JCO.2008.18.7724

10.1002/pbc.24648

10.1038/cgt.2011.82

10.1038/sj.mt.6300020

10.1158/1078-0432.CCR-09-1292

10.1182/blood-2013-09-528851

10.1016/j.bbrc.2009.08.062

10.1038/nri2358

10.1158/1078-0432.CCR-12-2733

Stepkowski SM . Molecular targets for existing and novel immunosuppressive drugs. Expert Rev Mol Med. 2000;2 (4):1–23.

10.2217/imt.12.64

Thông tin
Thông tin xuất bản

Neuro-Oncology

Tập 17 Số 12

1568-1577

Thông tin tác giả